N※N

NZ Health Guidance Criticized for Delaying EDS/HSD Diagnosis

  //health-fitness.news-articles.net/content/2026/ .. e-criticized-for-delaying-eds-hsd-diagnosis.html
  Published in Health and Fitness on Sunday, March 1st 2026 at 19:44 GMT by rnz
      Locales:

Wellington, New Zealand - March 2nd, 2026 - A growing chorus of patients and medical specialists are condemning official New Zealand health guidance concerning Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorder (HSD), labeling it as "incredibly damaging" and contributing to years of diagnostic delays and inadequate care. A recent investigation by RNZ has brought to light the deep frustration within the EDS and HSD community, revealing a system that many believe actively hinders proper diagnosis and support.

For years, individuals living with these chronic conditions have fought for recognition, facing significant hurdles in accessing timely diagnosis and effective treatment. Advocates argue that the Ministry of Health's current approach isn't simply falling short - it's exacerbating the problem, leaving countless New Zealanders to suffer in silence and navigate a healthcare landscape marked by disbelief and dismissal.

Understanding EDS and HSD

EDS isn't a single condition, but rather a group of heritable disorders affecting connective tissues - the scaffolding that provides support to skin, tendons, ligaments, and organs. HSD, while sharing many symptoms, describes individuals with hypermobile joints who don't necessarily meet the strict criteria for a specific EDS subtype. Both conditions manifest with a wide spectrum of symptoms, including chronic pain, persistent fatigue, joint instability leading to frequent dislocations and subluxations, digestive issues, and potentially serious cardiovascular complications. The variability of symptoms makes diagnosis notoriously challenging.

The Core of the Controversy: A Focus on Exclusion

The Ministry of Health's guidance to physicians emphasizes the process of excluding other possible diagnoses before considering EDS or HSD. Critics argue this approach places an undue burden on patients, forcing them to undergo a lengthy and often frustrating series of tests to rule out alternative explanations for their symptoms. This "rule out everything else first" methodology, they say, actively discourages clinicians from proactively considering EDS or HSD, even when symptoms strongly suggest their presence.

Dr. Nicola Spurrier, a UK-based specialist in connective tissue disorders, is particularly vocal in her criticism. "It's incredibly damaging," she states. "This approach reinforces the misconception that these are rare and exceptionally difficult to diagnose, and dissuades clinicians from adding them to their differential diagnosis. It leads to dismissal, delays, and ultimately, a worsening of patient outcomes."

The Human Cost: Gaslighting and Invisible Illness

The impact of this official guidance is acutely felt by individuals like Sarah, a New Zealander diagnosed with HSD after years of debilitating symptoms. She describes the experience of seeking help as feeling "invisible," constantly forced to justify her pain and fatigue. "You're constantly having to prove you're not faking it, that it's not 'just' fatigue. It just feels like you're being gaslit."

Emily's story echoes this sentiment. She spent 35 years seeking answers before receiving a diagnosis, enduring dismissive attitudes from multiple healthcare professionals. She believes the current advice provides clinicians with a convenient justification for dismissing her concerns. "It gives them a way to say, 'I followed the guidelines, and it doesn't fit EDS or HSD,' without truly investigating further."

The Ripple Effects of Delayed Diagnosis

The consequences of delayed or missed diagnoses are far-reaching. Patients experience prolonged suffering, worsening symptoms, reduced quality of life, and increased psychological distress. Without a diagnosis, access to appropriate medical care, physiotherapy, pain management, and vital support services remains elusive. The constant struggle to be believed can lead to self-blame, feelings of isolation, and a breakdown of trust in the healthcare system.

Calls for Change: Aligning with International Best Practice

Advocates are urging the Ministry of Health to overhaul its guidance, bringing it in line with current international best practices. Key recommendations include:

• Acknowledging the Complexity: Recognizing the wide range of presentations and symptom variability within EDS and HSD.
• Prioritizing Clinical Judgment: Encouraging clinicians to consider EDS and HSD as possibilities, even when other diagnoses haven't been definitively excluded.
• Investing in Education: Providing comprehensive training for healthcare professionals to improve their understanding of these conditions and enhance diagnostic accuracy.

Ministry Response and Future Outlook The Ministry of Health has acknowledged the concerns raised and stated that the advice is currently under review. They maintain that the guidance is intended to aid in differential diagnosis, not to create a barrier to diagnosis. However, patient advocates remain skeptical, arguing that a more substantial and proactive response is needed to address the systemic issues hindering care. The future wellbeing of thousands of New Zealanders living with EDS and HSD hinges on a commitment to recognizing, understanding, and effectively managing these complex and often debilitating conditions.